Join to view full profile
777 Scudders Mill RdBldg 2Princeton, NJ 08540
Dr. Elliott is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2011 - 2013
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2011- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2007 - 2010
Duke University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2027
PA State Medical License Active through 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014
- Member AOA, 2010
Publications & Presentations
PubMed
- 368 citationsEpcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.Catherine Thieblemont, Tycel Phillips, Herve Ghesquieres, Chan Y Cheah, Michael Roost Clausen
Journal of Clinical Oncology. 2023-04-20 - 8 citationsCost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopeniaGabriel Tremblay, Mike Dolph, Menaka Bhor, Qayyim Said, Anuja Roy
Clinicoeconomics and Outcomes Research. 2018-11-05 - 14 citationsRestoring hemostasis: fibrinogen concentrate versus cryoprecipitate.Brian M Elliott, Louis M. Aledort
Expert Review of Hematology. 2013-06-01
Professional Memberships
- Member
- Member
Industry Relationships
- VP, Hematology, Genmab US2019 - Present
- Employed, NovartisUS Medical Director for Exjade/Jadenu, Promacta, and Midostaurin. Global development for Eltrombopag and Crizanlizumab.2014 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
